To measure the rate of bone loss while patients are
undergoing cancer treatment, we initiated several routes of
study to accurately define and display the bone remodeling
occurring at the systemic and microscopic levels.
These routes of study include two human feasibility trials,
effects of radiation on in vivo skeletal system, and the
study of in vitro marrow stromal cells to understand the
mechanisms of cancer treatment related bone loss.
